CGClara Gram Gjesdal

Clara Gram Gjesdal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Clara Gram Gjesdal has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Impact of lean mass and fat mass on bone mineral density: The Hordaland Health Study

    by Clara G. Gjesdal, Johan I. Halse, Geir Egil Eide, Johan G. Brun, Grethe S. Tell


  • Open Access

    Plasma Homocysteine, Folate, and Vitamin B12 and the Risk of Hip Fracture: The Hordaland Homocysteine Study

    by Clara Gram Gjesdal, Stein Emil Vollset, Per Magne Ueland, Helga Refsum, Haakon E Meyer, Grethe S Tell

    Homocysteine and related factors were evaluated as risk factors for subsequent hip fractures among 4766 elderly men and women. High levels of homocysteine and low levels of folate predicted fracture, whereas vitamin B12 and genotypes were not related to fracture risk. High homocysteine may be a modifiable risk factor for hip fracture. Introduction: Elevated plasma total homocysteine (tHcy) and deficiencies of folate and vitamin B12 are associated with risk of osteoporosis and fracture. We examined whether plasma levels of tHcy, folate, and vitamin B12 and the methylenetetrahydrofolate reductase (MTHFR) 677C→T and 1298C→T polymorphisms predicted hip fracture. Materials and Methods: This was a population‐based prospective study of 2639 women and 2127 men who were 65–67 yr at enrollment in 1992–1993. Information on hip fracture was obtained from computerized records of discharge diagnoses from all hospitalizations in the region in the period between enrollment and November 30, 2005. Cox proportional hazard regression was used to estimate fracture risk according to levels of plasma tHcy, folate, and vitamin B12 and for different genotypes. Results: Over a median follow‐up period of 12.6 yr, hip fracture was recorded in 184 (7.0%) women and 90 (4.2%) men. The adjusted hazard ratio (95% CI) for fracture in subjects with high (≥15 μM) compared with low levels (12 level or MTHFR genotype was not significantly related to risk of fracture after adjustments for confounding factors. The association between tHcy and risk of hip fracture was only slightly weakened by adjustments for plasma levels of vitamin B12 and folate. Conclusions: tHcy seems to be a predictor for hip fracture among elderly men and women. Folate was a predictor among women only, whereas vitamin B12 and MTHFR genotype did not predict hip fracture. Our data corroborate the hypothesis that homocysteine may play a role in the pathogenesis of osteoporotic fractures.


  • Open Access

    Plasma Total Homocysteine Level and Bone Mineral Density

    by Clara Gram Gjesdal, Stein Emil Vollset, Per Magne Ueland, Helga Refsum, Christian A. Drevon, Håkon K. Gjessing, Grethe S. Tell

    Elevated plasma concentration of total homocysteine (tHcy) and deficiency of vitamins related to its metabolism, such as vitamin B12 and folate, have been associated with various disorders, including cardiovascular disease1,2 and Alzheimer disease.3 Likewise, the common 677C→T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene has been studied extensively in relation to these diseases because the homozygous TT genotype is associated with reduced enzyme activity and higher levels of tHcy compared with the more common CC genotype.4


  • Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values

    by Clara Gram Gjesdal, Sylvi J. Aanderud, Hans-Jacob Haga, Johan G. Brun, Grethe S. Tell

    The aim of this study was to compare bone mineral density (BMD) in a population-based sample of middle-aged and older Norwegians, with reference values provided by the manufacturer of the densitometer (Lunar) in order to evaluate whether these reference values are suitable for Norwegians. Additional aims were to estimate the prevalence of osteoporosis. Bone mineral density of the hip and total body was measured by dual-energy X-ray absorptiometry in 2303 men and 3105 women 47–50 and 71–75 years old, respectively, in western Norway, as part of the Hordaland Health Study (HUSK). Of these, 3403 white individuals were free of medications or diseases known to influence bone metabolism (reference group). Compared with the Lunar reference population, men and older women had a slightly but significantly lower BMD of trochanter and total femur and middle aged women had significantly higher total body BMD. Except for the higher mean BMD of total body among middle-aged women and the uniformly lower BMD values of Ward’s triangle, the deviations from the reference values of the manufacturer were less than 4%. Approximately 2.6% of middle-aged men vs 0.9% of middle-aged women were classified as osteoporotic on the basis of BMD of femoral neck. While the BMD values for femoral neck in this healthy Norwegian population are similar to the reference population of Lunar, the values of trochanter and total femur are lower in all groups except middle-aged women; however, the discrepancies are not of sufficient magnitude to warrant rejection of this commonly used database among Norwegians. Use of the young adult means from the Lunar reference database classified a higher proportion of middle-aged men than women as osteoporotic and osteopenic.